Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fufang shelong capsule
- Development stage
- Unknown
- Lead developer
- Buchang Pharmaceuticals
- Administration
- Oral
01
Overview
Fufang Shelong Capsule is a Traditional Chinese Medicine (TCM) formulation primarily used for the treatment of chronic inflammatory musculoskeletal conditions and the sequelae of cerebrovascular accidents. The formulation is categorized under the "Wind-Dampness-Cold-Obstruction" therapeutic class in TCM and typically contains a complex mixture of animal-derived and botanical ingredients, including *Agkistrodon acutus* (snake), *Lumbricus* (earth dragon), *Scorpio* (scorpion), and *Hirudo* (leech). These components are believed to work synergistically to dispel wind, unblock collaterals, improve microcirculation, and alleviate pain. Pharmacological studies suggest that the capsule exerts anti-inflammatory and analgesic effects by modulating pro-inflammatory cytokines and inhibiting inflammatory pathways. It is widely manufactured in China, most notably by Shaanxi Buchang Pharmaceuticals, and is indicated for rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis.
- Brand names
- 复方蛇龙胶囊Fufang Shelong Capsule
- Other names
- Compound Shelong Capsule
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))PTGS2 (Prostaglandin-Endoperoxide Synthase 2)IL1B (Interleukin-1 beta)
Beyond the preview
Go deeper on fufang shelong capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fufang shelong capsule.